Simplifying Global Compliance
CMS Updates TAVR Coverage, Adding CoreValve Trial Use
Devices & Diagnostics Letter
Medicare will cover patients enrolled in Medtronic’s pivotal trial of the CoreValve system, under an Aug. 10 revision to the Centers for Medicare & Medicaid Services’ (CMS) coverage policy on transcatheter aortic valve replacement (TAVR).
To View This Article:
Subscribe To Devices & Diagnostics Letter
Buy This Article Now
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing